4//SEC Filing
SOLTA MEDICAL INC 4
Accession 0001181431-14-004064
CIK 0001171298operating
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 8:29 PM ET
Size
20.4 KB
Accession
0001181431-14-004064
Insider Transaction Report
Form 4
Ku Mingo
Vice President of Global Sales
Transactions
- Disposition to Issuer
Common Stock
2014-01-23$2.92/sh−41,378$120,824→ 0 total - Exercise/Conversion
Performance Restricted Stock Unit
2014-01-23−5,963→ 0 totalExp: 2023-02-04→ Common Stock (5,963 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2014-01-23$1.55/sh−20,000$31,000→ 0 totalExercise: $1.37Exp: 2018-12-31→ Common Stock (20,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2014-01-23$1.41/sh−2,000$2,820→ 0 totalExercise: $1.51Exp: 2019-07-31→ Common Stock (2,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2014-01-23$0.15/sh−50,000$7,500→ 0 totalExercise: $2.77Exp: 2022-12-11→ Common Stock (50,000 underlying) - Exercise/Conversion
Common Stock
2014-01-23+5,963→ 5,963 total - Disposition to Issuer
Common Stock
2014-01-23$2.92/sh−5,963$17,412→ 0 total - Disposition to Issuer
Employee Stock Option (Right to Buy)
2014-01-23$0.17/sh−3,000$510→ 0 totalExercise: $2.75Exp: 2021-01-31→ Common Stock (3,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2014-01-23$0.36/sh−2,500$900→ 0 totalExercise: $2.56Exp: 2023-01-31→ Common Stock (2,500 underlying)
Footnotes (3)
- [F1]Disposed of pursuant to the merger of the Issuer with Valeant Pharmaceuticals International, a Delaware corporation (the "Merger"), at the merger consideration of $2.92 per share (the "Merger Consideration"). Includes 28,166 shares deemed acquired pursuant to the grant of restricted stock units ("RSU s") on various dates. The vesting of the RSU's was accelerated in connection with the Merger.
- [F2]Each performance right represented a contingent right to receive a share of Issuer common stock based on the Issuer's stock price performance. In connection with the Merger, the vesting (thus, the settlement) of the performance right was accelerated.
- [F3]This option, which had become fully vested and exercisable, was cancelled at the closing of the Merger in exchange for a cash payment equal to the product of (a) the number of shares underlying this option and (b) the difference between the Merger Consideration and the exercise price per share of this option.
Documents
Issuer
SOLTA MEDICAL INC
CIK 0001171298
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001171298
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 8:29 PM ET
- Size
- 20.4 KB